Search bioRxivSearch

bioRxiv · 10.1101/285577

Prestimulus neural alpha power predicts confidence in discriminating identical tones

Abstract

There is growing evidence that the power of prestimulus neural alpha oscillations ([~]10 Hz) holds information on a perceivers bias or confidence in an ensuing perceptual decision, rather than perceptual sensitivity per se. Obviously, however, confidence also depends on the physical evidence available in the stimulus as well as on task performance. If prestimulus alpha power has a direct impact on decision confidence, this link should hold independent of variations in stimulus evidence and performance. We tested this assertion in a paradigm where human listeners (n = 17) rated their confidence in the discrimination of the pitch of two identical tones. Lower prestimulus alpha power in the electroencephalogram (EEG) was predictive of higher confidence ratings, but not of the decision outcome (i.e., judging the first or the second tone as being higher in pitch). Importantly, the link between prestimulus alpha power and decision confidence was not mediated by auditory evoked activity. Our findings demonstrate that the link between prestimulus alpha power and decision confidence does not hinge on physical evidence in the stimulus or task performance. Instead, these results speak to a model wherein low prestimulus alpha power increases neural baseline excitability, which is reflected in enhanced stimulus-evoked neural responses and higher confidence.\n\nSignificance statementIn order to understand the mechanistic relevance of neural oscillations for perception, we here relate these directly to changes in human auditory decision confidence. Human subjects rated their confidence in the discrimination of the pitch of two tones, which were, unbeknownst to the listener, physically identical. In the absence of changing evidence in the physical stimulus or changes in task performance, we demonstrate that prestimulus alpha power negatively relates to decision confidence. Our results support a model of cortical alpha oscillations as a proxy for neural baseline excitability in which lower prestimulus alpha power does not lead to more precise but rather to overall amplified neural representations.

Source connections

Explore related subjects

Keep this discovery

BibTeXRIS

Woestmann, M., Waschke, L., Obleser, J.. 2018-03-20. Prestimulus neural alpha power predicts confidence in discriminating identical tones. https://doi.org/10.1101/285577

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience